ARPA-H launched the Genetics Medicines and Individualized Manufacturing for Everyone (GIVE) program, committing up to $125 million to build a domestic network for automated, on-demand RNA drug manufacturing. The program aims to integrate near-point-of-care production with automated quality-control testing.